The Recombinant DNA Debate by Brown, Richard E.
Ouachita Baptist University
Scholarly Commons @ Ouachita
Honors Theses Carl Goodson Honors Program
1979
The Recombinant DNA Debate
Richard E. Brown
Ouachita Baptist University
Follow this and additional works at: https://scholarlycommons.obu.edu/honors_theses
Part of the Cells Commons
This Thesis is brought to you for free and open access by the Carl Goodson Honors Program at Scholarly Commons @ Ouachita. It has been accepted
for inclusion in Honors Theses by an authorized administrator of Scholarly Commons @ Ouachita. For more information, please contact
mortensona@obu.edu.
Recommended Citation
Brown, Richard E., "The Recombinant DNA Debate" (1979). Honors Theses. 610.
https://scholarlycommons.obu.edu/honors_theses/610
OUACHITA BAPTIST UNIVERSITY 
HONORS INDEPENDENT STUDY 
THE RECOMBINANT DNA DEBA'l'E 
·. 
Richard E. Brown, Jr. 
April 10, 1979 
1-1 r·c;7 . J- 72 5 J 
1? " () 
The questions surrounding the recombinant DNA research 
debate are not just questions of technique and safety. They 
involve the driving forces of scientific research, especially 
those premises and presuppositions concerning the exp~nsion 
of knowledge versus our ability to use that knowledge wisely. 
Basically, we ask if policy--scientific, industrial, or 
political--should be an integral part of our future steps in 
recombinant DNA research and development. 
It is obvious from past mistakes involving pollution, 
waste of fossil fuels, and overmechanization that we must 
try to avoid the crucial tendency that technology has of 
overrunning common sense and moral guidelines. This is 
especially true in light of the fact that we are looking at 
an area of research in which results are probably the most 
unpredictable of any area of biochemistry. There comes a 
point at which the scientist, seeing himself as providing 
good for mankind, becomes hostile at the thought of the 
regulator burdening down progress with red tape. The regulator, 
on the other hand, views the scientist as being too ambitious 
and uncontrolled, and sees himself as a protector of the 
"real world" from the eccentricities of the research scien-
tist. 
In the recombinant DNA question, this conflict becomes 
strikingly real. The techniques and ideas are no longer 




A method of reducing risks while 1uaintaining the potential 
benefits of recombinant DNA research must be found. On this 
point, there seems to be widespread agreement among scientists 
and lay-people. The· real debate begins when the regulations for 
accomplishing this goal are proposed. Not only are the regulations 
themselves debated, but the validity of them is also a focal 
point of debate. Here, the challenge to validity comes from the 
rapidly changing knowledge concerning recombinant DNA techniques. 
Possibly, the answer is not in a set of £ixed rules, but in rules 
that can be easily accommodated to current knowledge without en-
dangering the public or the environment. 
Therefore, the following is a review of facts concerning 
recombinant DNA research, starting with the basic premises of 
molecular genetics and then reviewing National Institutes of 
Health guidelines, testimony before the United States House of 
Representatives Subcommittee on Science and Technology, and 
transcripts of the National Academy of Sciences' Forum on Recom-
binant DNA research. Within this review, the risks, benefits, 
and existing regulations will be discussed, concluding with a 
general summary and commentary. It is hoped that this paper will 
serve as an informative summary of the author's three semester 
study of the recombinant DNA research policy. debate. 
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To understand the nature of deoxyribonucleic acids, 
hereafter referred to as DNA, one must f·irst gain an appreciation 
for the cell.s and some viruses in which DNA directs chemical 
re.actions in the cycles which we recognize as life. In the 
case of viruses, the distinction betw·een life and mere 
chemical reactions is still not clear, but the basic mechanisms 
of chemistry that are involved are the same as for the cells. 
The separation of organic and inorqanic chemistry, as in 
livinq and nc:m-livinq, has no real bioloqical basis. 
However, even throuqh the first quarter of the twentieth 
century, there was a stronq tendency towards a theory of 
"vitalism", that certain rules outside of the laws of chemistry 
differentiated between living and non-living entities. 1 As 
techniques became more sophisticated, the existence of certain 
macromolecules, especially proteins, was demonstrated. It 
was not until the elucidation of the bas.ic structure of proteins 
as being alpha helical that immense strides were tnade towards 
understanding basic chemistry which determines the direction 
. . 2 
of l1fe. The direction of biochemical research before the eluci-
dation of the m<::~lecular structure' of proteins was toward studies 
3 
on metabolism of the cell. However, as metabolic pathways 
within the cell were worked out, it was found that a specific 
enzyme must mediate each step of individual pathways. This be-
came especially obv~ous. in the elucidation of the Embden-Meyerhof 
pathway, which is the stepwise degradation of glucos.e to pyruvic 
--- - ----·- r - ----- ----·-
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acid. It was noted that enzymes caused reactions between 
molecules to occur at an increased rate, yet at a lower 
energy level than the reaction would normally require, i.e. 
4 
at a lowered activation energy. Yet the manner of the 
initial formation of enzymes was still unknown. 
It is here that the role of DNA became of prime interest. 
Together with its associated proteins, DNA was discovered in 
1890 by the German chemist, Miescher, in the nuclei obtained from 
pus. By the use of specific staining procedures, DNA was localized 
in the chromosomes in the nuclei of cells by Feulgen in 1924, 
and 20 years later, DNA was shown to be the crucial molecule of 
heredity by Avery, McCarty, and McLeod. 5 Chargaff, by use of 
paper chromatography, was able to anal.·ze the nucleotide composi-
tion of DNA molecules from a number of organisms. He showed that 
the four nucleotides are not found in equal amounts and that their 
ratios to each other vary from species to species. This opened 
up the possibility of genetic specificity according to precise 
nucleotide arrangement. It later became evident that the amount 
of adenine was always equal to the amount of thymine, and the 
amount of guanine was always equal to the amount of cytosine. 
The real impact of these results was not really evident until 
the three dimensional structure of DNA was established.6 
The development of x-ray diffraction analysis proved to be a 
tremendous asset in working out the structure of DNA. Using tech-
niques developed in the X-ray analysis of proteins, high quality 
diffraction patterns were obtained by Wilkins and Franklin, 
5 
working in London at King's College in 1952. Then in 1953, 
following the theories of X-ray diffraction established by 
scientists working on protein structure, Watson and Crick 
were able to deduce the structure of DNA as being a complementary 
double helix. This was a momentous breakthrough, as scientists 
now had a real molecular object about which they could think 
obiectivelv in terms of established chemical mechanisms such 
as hydrogen bonding. Immediately, the mechanism for replication 
could be theorized as one strand serving as a template for 
the building of another complementary strand. It was at 
this point that molecular genetics had its beqinnings. 7 
The area of recombinant DNA research is deeply involved 
in the fundamentals of molecular biology, thus a rigorous 
treatment of the subject would seem most appropriate. 
However, it seems prudent to give a more concise and relevant 
background, thus we will look at what DNA is and then point 
out some of its activity in a living system. 
DNA is the macromolecule that is the principal component 
of the chromosome, the structure within the cell that is the 
storage place for the "information'' necessary to sustain the 
cell in the living state. The cell that we speak of may be 
a single-celled bacteria or one of a group of cells which 
form a higher organism. In either case, each cell carries 
the information it needs to sustain the organism. Not all 
of the information is used at once; instead, the chromosome 
also carries mechanisms for the timinq of gene expression, 
6 
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dependinq on staqe of development or surroundinq conditions. 
The DNA molecule itself varies in lenqth from orqanism 
to orqanism and usually consists of two complementary polymeric 
chains twisted about each other in the form of a reqular 
double helix. Each chain is a polynucleotide, each nucleotide 
beinq made up of a nitroqen base, a deoxyribose suqar and a 
phosphate qroup. There are four nitrogen bases: cytosine, 
guanine, adenine, and thymine. The two chains are joined 
together by weak bonds between complementary bases, that is, 
cytosine is always paired with guanine and adenine is always 
paired with thymine. 9 The number of different DNA molecules 
caused by arrangements of nucleotides is given by the expression 
4n, where n is the number of nucleotides in a given molecule. 10 
Even in an extremely small virus, ~uch as tl74, with only a 
single stranded DNA, there are 5,375 nucleotides, or 4 5395 
possible combinations. In a mammalian cell, there are approximately 
7 11 
1 x 10 nucleotides. 
Replication of DNA occurs by the unwinding of the 
strands and attachment of free deoxynucleoside-triphosphates 
to their now unpaired complementary nucleotides. It should 
be noted that some lower bacteria that do not have well 
defined nuclei, called prokaryotic cells, have single stranded 
DNA which replicates by a somewhat different mechanism, but 
complementary base pairing is still the essential step. 12 
In the case of the making of a protein, the weak bonds 
that make r e p l icati on possible also make the first step of 
protein synthesis, transcription, possible. Again, complementary 
7 
bases attach to the DNA, but this time they are attached to 
ribose sugars instead of deoxyribose s·,;gars. Another difference 
is that the nucleotide thymine is replaced by uracil. Thus, 
when the polynucleotide-ribose sugar chain is complete·, it 
detaches and is known as RNA. It has the same information 
that DNA has, with the exception that each RNA nucleotide is the 
complement of the corresponding nucleotide on the original DNA 
strand. An important point here is that any mistake made in 
the copying of DNA will be continued through successive 
replications, but since RNA is not a self-replicating molecule, 
any mistake made in its transcription will not be propagated 
and will usually result in a nonfunctional protein being 
produced, if one is produced at a11. 13 
The RNA strand contains successive bases which are "read" 
in a process called transcription by other RNA molecules 
with amino acids attached. The RNA units which result from 
transcription from DNA are known as messenger RNAs(m-RNA), 
while the RNA units that ·"read" the m-RNAs and link the 
proper proteins together are known as trans.fer RNAs, or t-RNAs. 
The t-RNA contains approximately 80 nucleotides in a chain 
that folds by means of weak bonds into a cloverleaf shape. 
Each loop of the cloverleaf (Fig.l) has a particular function; 
one loop binds to the ribosomal surface, another recognizes 
activating enzymes, and there is an area containing the 
anticodon, and an open end which holds the amino acid moiety 
which will become part of the protein to be made. 
The start of protein synthesis (Fig.2) is the moving of 
8 I LEU 
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The above figure is a schematic diagram of a t- RNA 
molecule, attaching by means of its anticodon to the 
complementary bases of the codon on m- RNA. Both m- RNA 
and t- RNA are single stranded polynucleotides. Loops 
are formed by hydrogen bonding of complementary nucleotides 
within the t-RNA molecule. 
1. Binding to the ribosomal surface may involve this 
loop. 
2. Anticodon loop. 
3. Possibly involved in binding to activating en-
zymes. 
"Leu" represents the amino acid leucine, which will be 






Growing polypeptide chain, attached 
by a t-RNA group to the protein 
binding site. 
2. The next amino acid enters the amino 
acyl site attached to another t-RNA. 
A specific enzyme mediates the trans-
fer of the first two amino acids to the 
third amino acid. 
3. Ejection of t-RNA from the "P" site. 
4. Growing polypeptide chain moves from 
the · "A" site to the 11 P" site . S i mu 1-
taneously, the m-RNA moves to place 
the next codon (n+2) at the "A" site. 
This figure shows the steps of formation of a polypeptide 
chain. The "P" and "A" binding sites are shown within a schematic 
diagram of a ribosome. (Figures 1 and 2 taken from Molecular 
Biology of The Gene, 3d ed. by J.D. Watson.) 
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m-RNA to a ribosome which splits into two subunits. A 
complex is formed with the smaller subunit (30S), the t-RNA 
carrying the first amino acid, which is always formylated 
methionine, and the m-RNA molecule. This complex is joined by 
t;tJS~ the larger ribosomal subunit (70S) which completes the full 
ribosome along which protein synthesis can occur. Specific 
proteins assist in all of these attachments. Each ribosome 
has two places for the t-RNA to a·ttach to m-RNA. These are 
called the P (peptidyl) and A (amino acyl) sites. Each 
attachment locus on m-RNA is made up of three nucleotides 
called the codon which codes for one of twentv amino acids. 
The anticodon, three complementary nucleotides on a loop of 
the t-RNA, binds to the m-RNA codon. Thus the proper amino 
acid is coded for. When both the P and A binding sites are 
filled, peptidyl transferase, an enzyme, joins the amino 
acids together, and the first t-RNA moves out of the P 
binding site, leaving the two amino acids, formylated 
methionine and the second amino acid, attached to the t-RNA 
occupying the A site. Now the m-RNA and the ribosome move rela-
tive to each other, and the t-RNA carrying the two unit peptide 
chain is positioned in the P site. The now vacant A site accepts 
another t-RNA with its associated amino acid, which attaches to 
the growing peptide chain by a repetition of the above process. 
Thus, a protein is synthesized from the information coded ori-
ginally on DNA. The time required to complete this process for a 
protein containing 300 to.400 amino acids is about 10 to 20 seconds. 
11 
Termination is accomplished by specific codons on the m-RNA 
that are not complementary to a t-RNA anticodon, but are read 
by specific protein release factors that stop elongation of 
the chain and release the t-RNA at the terminal end. Note that 
many ribosomes can attach to an m-RNA at once, thus several 
1 . d h . b . h . d . 1 1 14 po ypept1 e c a1ns can e synt es1ze s+mu taneous y. 
The last area of relevant background is natural recombina-
tion. Recombinants have been observed even as early as 
Mendel's garden pea experiments. The recombinant part of 
his experiments dealt with the breedinq of oea olants differinq 
in more than one character, in this case, round versus wrinkled 
and yellow versus green. Mendel showed that round and yellow 
are dominant over wrinkled and green, that is if round and 
yellow peas which over successive generations bred true were 
crossed with wrinkled and green peas which also have bred true, 
the resulting peas would have a phenotype (physical structure) 
of round and yellow, but a genotype (genetic structure) of 
RrYy. (R is round, r is wrinkled, Y is yellow, andy is green.) 
The peas produced were called the F 1 generation. He then 
cross~d the F1 generation within itself and found that the 
resultinq F~ qeneration had the followinq phenotypes: the two 
~ 
oriqinal phenotypes (round, yellow; wrinkled, qreen) plus two 
new tvpes, the recombinants, wrinkled yellow and round oreen. 
The interpretation is that any one qamete from the F1 qeneration 
contains all the possible combinations of traits from each qene 
pair. Therefore, RrYv would vield four possibie qametes: RY, 
12 
rv, rY, Rv, but never Rr, Yv, YY, or RR. All four of these 
qamet.es are produced in virtuallv eoual numbers, and there is 
i.ndepe.ndent assortment of all the aenes. The result is obtained 
bv takina all possible combinations of RY, Rv, rY, rv, to 
produce the followinq ratio: 9 RY (round, vellow) , 3Rv (round, 
green), 3rY (wrinkled, vellow), lrv (wrinkled qreen). The 
middle two ohenotvoes would be recombinantst that is, thev have 
expressed both a dominant and a recessive trait as a result of 
a new recombining of gametes. 
This above phenomenon was explained using chromosomal 
theory in 1903 by Sutton, in his paper, The Chromosomes in Heredity. 
He said that the chromosomes are diploid and exist in identical 
pairs and during meiosis each gamete receives only one chromosome 
of each homologous pair. Thus, one pair could carry the gene 
for shape and another pair carry the g~ ne for color. Thus a 
gamete from the F 2 generation could easily have any one of four 
possible color/shape combinations. 
If, however, two qenes for distinctly different traits are 
located on the same qene, they will not underqo independent 
assortment. Thus, the number of qroups of linked qenes should 
equal the number of chromosomal pairs. However, this is never 
100% true. The Belgian cvtologist, Janssens, first described 
the mechanism of crossing over. When meiosis begins, homologous 
chromosomes pair at a synapse, parallel to each other. Then 
the chromosomes of each duplicate, thus giving four parallel 
···__:__-_--:_·l.:___:_ · -
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strands, or a tetrad of chromatids. The chromatids coil, 
causing tension which breaks two chromatids at corresponding 
places and they cross over and recombine with the other chromatid. 
The closer genes are on a chromosome, the less likely a break 
will occur between-them, thus by studying recombinants of 
crossing over, an effective method of mapping the genes was 
15 
d,iscovered. 
Random transfer of genetic material has also been observed. 
In the process called transformation, fragments of DNA are 
replicated and pass into the environment by excretion, or alter-
natively, a dying cell releases DNA fragments as its cell membrane 
rupture_s. Another cell, which is in a state of competence, will 
allow these fragments to enter through the cell membrane. The 
recipient cell is termed to be in a state of competence when it is 
not producing DNA-ase, an-enzyme which would break up the DNA 
chain when it reaches the cytoplasm, and when the cell membrane 
lacks its normal thick capsule which would not allow passage of 
macro-molecules such as DNA. Once the DNA fragments are within 
the recipient cell, there is only a five percent chance that the 
fragments will be similar enough to a segment of the host DNA that 
recombination will occur. If recombination does occur, the DNA 
fragment will become incorporated into the cellular DNA, with 
production of proteins coded for by the new DNA segment. If the 
newly produced proteins are toxic, a relatively harmless bacteria 
could become a source of toxic materials·. 
14 
Another method of DNA exchange can come in the form of 
·conjugation, where cells of the same species exchange genetic 
material. Conjugation is well documented in the bacteria 
Escherichia coli, which is a normal inhabitant of the lower 
intestinal tract of most primates, and has a circular DNA strand. 
The cell which initiates conjugation has a plasmid, in addition 
to its circular DNA. The plasmid is a piece of independent DNA 
that carries anywhere from 1 to 250 genes, and there can be as 
many as thirty plasmids per cell. The plasmid may replicate at 
any time, independent of the replication of the cell's ''main" 
genetic material. 
A plasmid is responsible for forming the sex pilus, a cellular 
extension which links two cells and enables the cell with the 
plasmid, called an F factor, to physically transport a copy of 
its circular DNA into the recipient cell. This is accomplished by 
the replication of the donor's DNA, and then a restriction 
endonuclease, an enzyme coded for by the F factor, cleaves the 
copy at a specific point. Now the DNA can pass through the sex 
pilus linearly, with the F factor attached to the end of the DNA 
that will enter the recipient cell last. Very seldom will the 
entire DNA copy and F factor pass through because the DNA is 
extremely fragile and usually breaks before the entire conjugation 
process is complete. Partial conjugation is sometimes referred 
to as sexduction. 
One danger of recombination can be seen in the activity of 
15 
plasmids. It has been found that many plasmids carry genes 
which code for proteins which resist the actions of many anti-
biotics, such as penicillin or streptomyocin. The resistance 
to these drugs is passed on by conjugation. Staphlococcus 
bacteria are especially noted for this phenomenon. There are 
certain plasmids in E. coli which produce antibiotics known as 
colicins which kill off E. coli's competition in the primate 
intestine, and let E. coli proliferate, causing serious intestinal 
disorders. 
A cell may obtain extracellular DNA via bacteriophages and 
viruses. A bacteriophage contains only DNA surrounded by a protein 
coat. It has a tail of protein fibers used for cellular attach-
ment. A virus contains either DNA or RNA, but never both. It, 
too, has a protein coat, but usually does not contain the elaborate 
attachment fibers of the bacteriophage. In action, the bacteria-
phages are restricted to bacteria; viruses are found in cells 
making up larger organisms. 
In the process known as transduction, a bacteriophage inserts 
its DNA into the host cell, leaving the protein coat outside the 
cell. Proteins coded for by the phage DNA rapidly break down host 
DNA and use cellular ribosomes for new protein coat production. 
New phages are produced that carry fragments of the host's DNA 
along with their own DNA. At this point, the cell lyses (splits 
open) and releases the phages into the environment. The phages 
find new hosts, and the DNA of the phage, still containing frag-
16 
ments of the former host's DNA, may recombine with the new 
host's DNA. Thus, phages serve as a vector for the transfer of 
DNA from one cell to another. It is also possible, using the 
proper bacteriophage, that such transfer can occur between 
bacteria of different species. 
In some cases, the viral DNA will be inserted into the 
cellular DNA and remain dormant through several cell divisions. 
Thus, many copies of the viral DNA are made when the host DNA 
replicates just before cell division and the cells produced have 
a differing genetic makeup because of the viral DNA insertion. 
Proteins from this insertion may or may not be expressed, depending 
on the environment and state that the cell is in. 16 
Recombinant DNA technology has its origin in the principles 
expressed above. Basically, this type of experiment involves 
chemical synthesis or isolation of one or more genes from an 
organism followed by an insertion of this DNA into the DNA of a 
host organism. This insertion is done in such a way that the 
host will replicate the inserted gene along with the host's original 
DNA. The replication of the gene insertion by the host cell is 
referred to as cloning. The word cloning as used here refers to 
the replication of foreign DNA inside a host cell, and not the 
complete copying of a higher organism. 
The most widely used organism for recombinant DNA experiments 
is Escherichia coli, because its genetic structure and biochemistry 
have been the most extensively studied of any organism. It is 
easy to obtain and grow in extremely pure cultures. The most widely 
17 
used strain is the K-12 strain of E. coli which exists naturally 
in the environment, but does not colonize the human intestinal 
tract. 
Restriction endonucleases, previously mentioned in conjunc-
tion with the F factor and conjugation, have been found in many 
other forms and there exists specific endonucleases that cleave 
at specific sites on DNA. The most useful of these used in re-
combination experiments are those which produce DNA fragments with 
"sticky" ends. "Sticky" ends result from the cleavage of DNA at 
recognition sites known as palindromes. In the English language, 
a palindrome can be read as the same phrase both left to right and 
right to left, for example, "MADAM I'M ADAM." In DNA, such a se-
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which, if in a plasmid, could be cleaved by the proper restriction 
endonuclease , 
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Now, if another DNA sea uence were cleaved bv the same endonuclease, 
with the exception that it has a series o f other nucleotides 
f o r mi ng a ge ne b etwe e n t h e G and A , we would s ee : 
----- A 
~--- G\ lC T T A A ,....._.... IlL Ill 
A T T C t G ~---
(n e w g e n e) 
B. 
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The restriction ligase catalyses the formation of the 
phosphodiester bonds to yield an intact strand. Once the amino 
acid product of the recombinant is known, it can be sequenced, 
and the DNA sequence of the gene it came from can be preclicted. 
Thus, certain genes can be synthesized in the laboratory, rather 
than isolated from a cell. 
Once the plasmid has been recombined with the desired DNA 
segment, it can be inserted into a host cell, usually the bacteria 
Escherichia coli, and the cloning will. occur. Normally, the 
host cell is not harmed by having as many as 100 plasmid copies 
inside it. To tell exactly which cells have the plasmid and which 
do not, the plasmid used contains a gene for antibiotic resistance. 
After the recombinant plasmids have been mixed with the desired 
host cells, an antibiotic is administered. Those cells that 
survive are the ones which have incorporated the plasmid. 
In order to insure that the newly incorporated gene will 
19 
synthesize a desired protein, the gene must be recognized by 
the host system as being part of its DNA. This is done by 
splicing the gene into a section of the plasmid that is next to 
a DNA sequence that controls whether or not the gene will be 
17 
transcribed. 
An excellent example of the utility of the recombina·nt DNA 
technique is in the production of the mammalian peptide hormone 
somatostatin. Somatostatin inhibits the secretion of a number of 
hormones including growth hormone, insulin, and glucagon. It has 
value in the treatment of pancreatitis and insulin dependent 
diabetes. Conventionally, it has been isolated in milligram 
quantities by extraction of the ground-up brain tissue of a half 
million sheep. 
' The DNA responsible for the production of somatostatin using 
recombinant DNA techniques was chemically synthesized and not 
isolated from mammalian DNA. The DNA fragments were linked using 
ligase enzymes. The gene was then inserted in a bacterial plasmid 
between a gene control sequence and a naturally occurring gene for 
a bacterial protein. Thus, the somatostatin was produced as 
an addition to the normally produced bacterial protein, and was 
not destroyed by the cell's natural defense systems. However, 
in this form, the somatostatin was not useable, so it was cleaved 
from the bacterial protein using chemi~al methods involving 
cyanogen bromide. One hundred grams of bacteria grown in approxi-
mately sixteen liters of culture resulted in milligram quantities 
18 
of active somatostatin being produced. 
20 
Another development showing the utility of recombinant 
DNA techniques involves the manufacture of insulin by Genetech 
Laboratories in California. The gene coding for the protein 
insulin has been isolated from pancreatic cells and in~erted 
into the DNA of E. coli by a method similar to the one used to 
. 19 insert the somatostatin gene into a bacterial plasm1d. 
In agriculture, recombinant DNA techniques are being used 
to enhance the efficiency of nitrogen fixation. All plants, 
including crop plants, need nitrogen in a useable form, such as 
ammonia, in order to sustain life. By recombination, the gene 
for nitrogen fixation may be isolated from bacteria which 
naturally exhibit this activity (which converts N2 in the atmos-
+ phere to NH 4 , ammonia). The isolated gene could be placed in 
the DNA of a crop plant, making the crop plant fix nitrogen for 
itself. Another possibility is that the qene could be placed 
in a bacteria or alqae known tO be part of the natural flora 
of the soil in which the crop grows. Then the source of ammonia 
for the plant would be the bacteria in the soil. Fertilization, 
which requires the makinq of fertilizer from petroleum products, 
could be vastly reduced. 20 
Other potential benefits, which will only be briefly men-
tioned here, include the discovery of the mechanism of gene regula-
tion in mammalian systems, nucleotide sequencinq in the complex 
DNA of higher animals and methods of differentiation of cells 
within the human embryo. Not only could inherited disorders be 
21 
pinpointed as to cause, but there is the possibility of gene 
repair to correct such defects by recombinant techniques. The 
manufacturing of pharmaceutical products could be Inade more 
efficient by reducing the use of animal tissue extracts. Proteins, 
such as the human clotting factor for hemophilacs, could be 
isolated in highly pure form. In cancer research, the protein 
interferon has been found to be a possible therapeutic substance 
with low toxicity. However, it is found in such low quantities 
that research concerning it has been slow at best. The cloning 
of interferon in bacteria is a possible means of obtaining 
workable quantities of the protein. Vaccines could be prepared 
in bacteria, using bacterial plasmids as the attachment point 
for viral genes. This would eliminate contamination by unidenti-
fiable viruses in the vaccine culture, a phenomenon which plagues 
chicken embryo vaccine cultures that are presently used. 21 
The orosoects and Possibilities seem endless. Recombinant 
DNA techniques seem to be almost a oanacea for even the qreatest 
~uman scourqes. But from the outset of this tvoe of work, there 
were many scientists who warned against the misuse of gene control 
and manipulation. In the May, 1974, Proceedinqs of the National 
Academv of Sciences, Cohen and Chanq from Stanford, Baver, 
Hillinq, and Goodman from the University of California at San 
Francisco, and Murrow of Johns Hopkins. reported the successful 
combininq of animal qenes with a bacterial DNA strand. The re-
combinant DNA formed was called a "chimera," from the hideous 
22 
monster of incongruous parts in Greek mythology. 
22 
Shortly after this announcement, eleven scientists, making 
up the Committee on Recombinant DNA Molecules under the National 
Academy of Sciences, wrote a letter* requesting a ban on three 
types of recombinant DNA experiments. Type I is the addition of 
genes to bacteria that would confer antibiotic resistance or 
cause the production of a toxin not normal to that bacteria. 
Type II is linking DNA from tumor causing viruses to bacterial 
plasmids. Type III is the combining of animal cell DNA with 
bacterial DNA. 
The letter stemmed from a meeting of the Gordon Research 
Conference on Nucleic Acids in 1973, in which Paul Berg of Stan-
ford University formed a committee which began the investigation 
of the problem under the auspices of the National Academy of 
. 23 Sc1ences. Some members of the committee were actively involved 
in recombinant DNA experiments, including Cohen and Boyer from 
Stanford, and Daniel Nathans, whose work on restriction enzymes 
in 1969 started the field of recombinant DNA research and won for 
him a share of the 1978 Nobel Prize in Medicine. 24 
Immediately, there was a furor in the scientific community. 
A new precedent had been set, that is, scientists asking other 
scientists to curtail research, and to decide among themselves, 
. bl' h d/ 'f mb' h t . 25 1n pu 1c, ow an or 1 reco 1nant DNA researc was o cont1nue. 
To compound problems, the ·potential benefits and risks were purely 
speculative, as no previous work had been done on genetic material 
crossing the species barrier. 
* APPENDIX I 
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Speculative risks incl de animal tumor viruses which might 
contaminate community air a d water supplies or the escape into 
air and water of normally h rml~ss bacteria containing gene 
additions coding for toxic ~roteins. 26 Since E. coli is a natural 
inhabitant of the human intf stinal tract, fears exist that re-
combinant E. coli could esc~pe a research laboratory via human 
vectors, and cause massive pidemics of intestinal disorders, or 
infections of the blood str.am. It has also been found that one 
segment df DNA may encode f r several different proteins, depending 
on the location of the segm$nt in question in relation to the seg-
ment being transcribed. Inlother words, an inserted segment 
might code for one protein ~Y itself, plus be at the beginning of 
the code for another protei , and at the end of the code for yet 
another. This overlapping always be predicted, and thus the 
proteins from a single reco inant insertion may be quite varied 
and unpredictable. I 
I 
by 
The above stated negat t ve aspects of the research, spurred on 
the self-imposed morator urn, caused a tempest of press interest. 
Scientists who were used to a secluded atmosphere of research and 
decision making were sudden y thrust in front of the camera artd: 
microphone. The main issue to the public was safety and head-
lines like "Bid to Ban Test Tube Super Germ" left the public with 
an impression of a f ew mad- · ap, eccentric scientists fooling 
around with dangerous subst nces for lack of anything better to 
work on. 
The f i rst attempt a t s If- regulation took p l ace in an a tmos-
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phere of eagerness to clear up the safety issue and put the facts 
before the public. One hundred forty scientists from seventeen 
countries gathered at Asilomar, California, in February of 1975, 
to discuss effects of the now eight-month old moratorium on re-
search with recombinant DNA and to come up with recommendations 
that might permit the research to continue. 
The first three days of the conference were mostly condolence 
sessions. Scientists were telling each other that their research 
was too good and important for safety regulations to intrude. 
It was observed by one person as like having the chairman of 
General Motors write the specification for safety belts." 28 
However, the evening before the final session, three lawyers gave 
presentations on the legal aspects of the research and the legal 
responsibilities of the researchers. The final speaker of the 
three, Professor Harold Green of the George Washington University 
Law School, hit home with his topic, "Conventional aspects of 
the law and how they may sneak up on you--in the form, say, of a 
29 
multi-million dollar lawsuit." 
The results of the final session showed the impact of the 
previous evening's speakers. A two-point safety program was 
outlined, one part dealing with physical laboratory containment 
of recombinant molecules and organisms, based on risk. The 
second point was a novel concept of biological containment, where 
a strain of E. coli was to be developed that would not colonize 
in the natural environment. 30 
25 
The next major step in regulation was taken by the National 
Institutes of Health. Basically, the NIH detailed the physical 
and biological containment recommendations of the As~lomar 
Conference. These guidelines, explained briefly below, were 
published in June of 1976. 31 
Physical containment will be discussed first, followed by 
biological containment. The lowest level of physical containment, 
Pl, involves the standard microbiological procedures of sterile 
technique and autoclaving. Open bench tops may be used, but all 
wastes must be stored and decontaminated daily before release into 
the environment. Experiments using Pl can at most involve· 
transfer of genetic material resulting from biological gene ex-
changes that can occur in nature. The P2 level involves experi-
ments that use bacteria that do not naturally exchange g~nes. 
It uses the same procedures as Pl, plus restricted entrance to 
the laboratory, 32 and an open front cabinet with inward air flow 
over the work surface, so that bacteria laden aerosols do not 
contaminate the worker. The air exhausted to the environment by 
these cabinets is first filtered to remove 99.997 percent of the 
organisms present in the air. At the P3 level, all of the above 
would be used, plus protective gloves, wrap around disposable gowns, 
and vacuum systems protected by filters and disinfectant traps. 
The P3 room itself is isolated from all other laboratories; air 
pressure is slightly below outside pressure so that organisms can 
pass in but not out when the doors are opened, and double door 
26 
systems are used. Ultraviolet light shields are used in all 
hoods in the laboratory. Experiments done under these conditions 
include use of embryonic, vertebrate and primate tissue, and DNA 
transfer from these tissues and their tumors to "crippled" host 
systems. "Crippled" hosts will be discussed under biological 
containment. P4 procedures are maximum containment, using 
class III cabinets used within the laboratory of all conduits. 
The class III cabinets used within the laboratory are gas tight 
and all materials passing in or out of them must be autoclaved. 
This requires attaching an autoclave to the cabinet. A second 
sterilization must be done before any materials leave the labora-
tory proper. Personnel entering and leaving the laboratory 
must shower and wear completely separate clothing when in the 
laboratory. Under the original regulations, P4 facilities would 
accommodate any recombinant DNA research, except DNA from cancer 
causing viruses, pathogens, drug resistant organisms, or genes for 
toxins. These experiments would be completely banned. 
Experience with these procedures of containment has been 
gained in the biological warfare laboratories of Fort Detrick, 
Maryland. The infection rates for workers in similarly equipped 
laboratories ranged from 7 infections per 100 person-years worked 
for Pl to 0.4 infections per 100 person-years worked for P3. 
P4 data is not available as no lab meeting such stringent require-
ments has even been built. Construction of a P4 facility is in 
progress at Fort Detrick. 33 
27 
Biological containment, using so called "crippled" hosts 
contains recombinant DNA molecules in vectors that will not 
endanger the environment. Usually, these "crippled" hosts are ones 
that will only survive in the laboratory, or will self destruct 
by not possessing the genes to synthesize their own cell wall or 
34 
replicate DNA outside of a narrow environment. 
E. coli K-12 was the first strain used in biological con-
tainment because of its inability to survive more than 48 hours 
within the human intestinal tract. It was originally isolated 
from a human patient 50 years ago and since then has been cultured 
under laboratory conditions with regularity. However, approximately 
1 in every one hundred million cells will pass through the intes-
tinal tract unharmed. In March, 1976, the NIH approved a safer 
host strain of E. coli K-12 developed by Roy Curtiss of the Uni-
versity of Alabama, and dubbed it E. coli K-12 Chi 1776. Chi 1776 
requires certain laboratory nutrients, is sensitive to bile salts, 
and is destroyed by sunlight. 35 
Another method of biological containment includes the use of 
the Charon Lambda bacteriophage, where the recombinant molecule 
is not in a bacteria, but is present in a type of virus that only 
attacks bacteria. The bacteriophage only stays in the bacteria 
long enough to replicate, then lyses the cell. Propagation by 
these means outside the laboratory is extremely difficult. It has 
10 . 
been found that fewer than 1 in 10 phages survive stomach condi-
tions (pH 3 for 2.75 hours), fewer than 2 in 10 7 survive 30 minutes 
in detergent conditions (1 percent sodium dodecyl sulfate) and 
28 
fewer than 3 in 10 6 survive in raw sewage. Those that do survive 
however, do not encounter bacteria in natural surroundings that 
will support their growth. There are two strains of. bacteria 
used for their growth in the laboratory, E. coli Chi 1953 and 
Chi 2098. Each has a survival rate 1000 times less than E. coli 
K-12. Neither colonizes the human or rat intestinal tract. 36 
The year after the publication of the NIH guidelines, there 
were two important sets of hearings on the recombinant DNA re-
search issue. The National Academy of Sciences Forum reviewed 
the advances in developing safe strains of E. coli and heard 
scientists who presented their cases concerning pharmaceutical 
and industrial applications, food production, genetic engineering, 
and problems of regulation and control. This forum differed 
from the Asilomar Conference in that the atmosphere was both 
philosophical and safety oriented indicating that more scientists 
were willing to take a long, hard look at recombinant DNA research 
before going into it headlong. Excerpts of this forum have been 
previously cited. 
The other siqnificant hearings were held before the Sub-
A 
~ ~ committee on Science, Research and Technology of the Committee on 
science and Technology, United States House of Representatives. 
These hearings were similar in content to the NAS Forum and were 
also characterized by a philosophical slant on the future uses of 
the technique and public involvement in decisions concerning 
recombinant DNA research. 
29 
Philosophically,- a major question has been how far should 
we go with the recombinant DNA techniques. Critics contend 
that the possibilities of bio-hazards have not been resolved, 
but merely covered up. They claim that even one case of 
bacterial escape from a containment facility will prevent a re-
containment of it or its prodigy. Dr. Ruth Hubbard of Harvard 
asks how safety guidelines can be established when the risks are 
unpredictable and unquantifiable. Dr. Willard Gaylin warns that 
by nature, disasters are not anticipated, otherwise, they are 
prevented. 
Inherent to the technique is the potentially dangerous 
violation of three billion years of evolution. According to 
Dr. Robert Sinsheimer, we cannot prove that such "quantum jumps" 
in genetics occur naturally in the evolutionary process. Some 
feel that this technique will take the path of nuclear technology, 
demonstrating itself in a "Hiroshima style" with a disaster caused 
by an escape of a lethal recombinant DNA chimera, followed by 
more peaceful, but nonetheless controversial uses such as genetic 
engineering on human cloning. According to those who oppose genetic 
engineering, the proliferation of recQ~binant DNA techniques would 
encourage a symbiotic relationship between geneticists and social 
visionaries who envision a "super race" much as was done during 
Hitler's Third Reich.37 
Those who favor recombinant DNA research usually have accepted 
the NIH guidelines and believe that genetic engineering in humans 
is f ar fe tched and not applicable to the direction of the research 
at the present time. It is the safety factor rather than the 
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philosophical factor which concerns citizens. 
Dr~ Sheldon Krimsky served on the Cambridqe (Massachusetts) 
Experimentation Review Board, which advised local officials 
whether recombinant DNA procedures should be allowed in the city. 
The citizen review board unanimously voted to allow the research 
up to the P3 level. However, the committee also required research 
to have separate requlators and promoters, additional review and 
monitorinq of the facilities, done by a qroup independent of the 
. . . . 38 
sponsor1nq 1nst1tut1on. 
In other cities, the same concern was arising, especially in 
those towns with large universities or pharmaceutical firms. 
Ann Arbor, Michigan, has both. Albert Wheeler, the mayor in 1977, 
stated that he is concerned that the NIH guidelines have not 
been enforced in industry. In testimony before the House Sub-
committee on Science Research and Technology, Mr. Wheeler said 
that he would allow research up to but not including the P4 level, 
and city officials would have to be notified when recombinant DNA 
experiments were being done at any level. He also proposed the 
formation of a citizens review board on the subject. 
The apparent lack of acceptance of NIH guidelines in industry 
is unfortunate, but the increasing influence of citizen review 
boards may force compliance. 39 Groups such as Genetics Group of 
Science for the People have pressured industry to comply with 
NIH guidelines and have included the general public in the decision-
making process on allowing recombinant DNA experiments to be done 
40 
in their communities. 
31 
In a statement by the Pharmaceutical Manufacturers Associa- ··· 
tion, acceptance of NIH guidelines by that group and most pharm-
aceutical manufacturers seemed widespread. In early_ 1977, NIH 
proposed a national registry for all recombinant DNA work, and 
the PMA seemed likely to accept this measure also. 
Most environmentalists ask for strict controls and along 
with them, prominent anti-DNA research scientists have asked 
that all recombinant DNA work be carried out in P4 facilities. 
This, in 1977, would have amounted to a complete ban on recom-
binant DNA work, as no P4 laboratories were in existence. 41 
Presently, only the NIH and Fort Detrick, Maryland, have the 
proper P4 facilities. 
Actual DNA legislation was proposed in early 1977 and for 
the most part, placed tremendous restrictions on recombinant 
DNA research. However, in late summer of 1977, many Congressmen 
backed away from their "worst case scenario" philosophy, at the 
urging of scientists and industry alike. One of the most 
tenable sets of principales was proposed by the American Society 
for Microbiology which basically asked for a national regulatory 
commission, preemption of local or state laws by federal regulations, 
and fines for failure to comply with federal legislation. 
The A.S.H. principles caused Senator Edward Kennedy to with-
draw his bill that would virtually halt recombinant DNA work and 
caused relaxed revisions in both House and Senate bills dealing 
'th mb' h 1 . 42 w~ reco ~nant DNA researc regu at~on. 
A major question still stands unresolved and that is of 
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enforcement. In the research done on the insulin gene and its 
transfer to bacteria, a vector was used that was not NIH approved 
as a biological containment vector. This prompted the statement 
that among those in graduate research, some follow the guidelines 
to a degree, others not at all, and it seems ''almost chic not to 
know the NIH rules." Even if the vector were safe, the.question of 
unfair advantage arises. Are those who abide by the rules being 
taken advantage of by those who do not? The short time it took to 
produce a successful insulin producing bacteria indicates that an 
f . d b 'bl 43 un a1r a vantage may e poss1 e. 
The last section will describe events in recombinant regula-
tion durinq 1978. In the July 28, 1978, Federal Register, the 
NIH published revisions of the original NIH guidelines for work on 
recombinant DNA. The major revisions include: 
1. Exemption from the restrictions of the guidelines 
certain experiments which are now considered to be 
safe. (Most of these experiments fell under the 
old Pl containment requirements.) 
2. Placing primary responsibility for assuring guideline 
compliance on the institution where research is done. 
3. Dropping the requirement for NIH notification when a 
Pl experiment was changed to a P3 experiment. 
4. Providing voluntary registrc:'ion of recombinant DNA 
experiments.44 
During hearings before the Senate Subcommittee on Science 
Technology and Space, a recommendation was made that the current 
NIH guidelines should not be enforced by the NIH but by another 
unnamed agency. They also suggested that all laws regulating the 
33 
research be national laws with a deemphasis on local and state 
regulations, except in special cases. In a minority report 
Senator Harrison Schmitt said the recommendations would result 
45 
in "umvarranted and excessive regulations." 
As an additional signal that regulations and bans were re-
laxing within the scientific community, Genetech, Inc. agreed 
to work with Eli Lily and Company to manufacture insulin by 
insertion of artificial insulin genes into plasmids of E. coli. 
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Large scale production is predicted in 2 to 5 years. However, 
bans and restrictions have not been so much the issue this year 
as has the role of the NIH. Prompted by the Senate Hearings 
during the late summer, a public hearing was held in Washington to 
discuss the proposed revisions in NIH guidelines. Very little 
medium ground was covered; the guidelines were either too stringent 
or too relaxed. Ambiguities were pointed out often. The NIH 
planned to publish final revisions, based on the hearings in 
47 
November, 1978. 
Finally, Joseph Califano announced the revisions in the NIH 
guidelines. Basically, they were unchanged from the guideline 
changes mentioned previously, but the reporting procedures for 
violations, illness, and accidents were clarified . The NIH re-
tained control over recombinant DNA guidelines, but greater public 
representation in hearings and decision on policy was required. 
Therefore, the recombinant DNA question has not been completely 
resolved, but an interim set of guidelines that have shown themselves 
adaptable to new facts and findings may help us to control a new 
48 
and powerful research tool. 
34 
In writing this paper, the author was amazed at the number 
of plausible arguments both for and against continued use of 
recombinant DNA techniques. It seems that each potential risk 
is counterbalanced by an equally convincing benefit. It would 
be ridiculous to assign numerical values to each risk and bene-
fit and settle the question forevermore by a mere bookkeeping 
system. Each individua~ experiment must be judged primarily on 
its specific risks and specific benefits, and secondarily, on its 
relationship to other recombinant DNA experiments and vice-versa. 
However, we must have broad guidelines to assist not only 
our cost-benefit analysis of individual experiments, but also to 
insure that once an experiment is approved for use, the experiment 
will be done safely. A safe experiment is one that combines bio-
logical and physical containment procedures such that organisms 
containing artificially recombined DNA will not be able to reproduce 
in the environment. In this writer's opinion, the current NIH 
guidelines, if enforced, would accomplish this goal. It must be 
noted that these guidelines must be open to change, as basic re-
search reveals more about the nature of recombinant DNA techniques. 
The purpose of the NIH guidelines should not be to dictate a set 
of one time rules, but to be flexible guidelines with respect to 
the current findings of basic research in the area of recombinant 
DNA. 
Another major factor to consider is enforcement of the guide-
lines. A workable set of guidelines without enforcement are of 
little value. Enforcement must come from the national as well as 
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local levels. Communities must take more responsibility towards 
deciding what types of experiments should be allowed to take 
place in 'their institutions, both academic and industrial. How-
ever, the communities must also have the assurance that a federal 
agency will back them up in their decision. Here again, we see 
that the federal government must show flexibility 1n guidelines 
and in recognizing the rights of communities to make intelligent 
decisions of scientific importance. 
This writer certainly does not call for a ban on recombinant 
DNA research. Rather, there should be regulations, such as the 
current NIH guidelines that can change as current knowledge dic-
tates. There should also be enforcement from both the community 
and federal levels in order to assure compliance with research 
guidelines. The future of recombinant DNA research lies not in 
doomsday scenarios of plague caused by recombinant bacteria. Nor 
does it lie in surrealistic extrapolations of potential uses, 
such as human cloning and super-races. The future of recombinant 
DNA research lies in the scientists' ability to conduct accurate 
research within the bounds set mutually by science and society, 
each being willing to change their position as the facts permit. 
f.?'"' 
LRTTERS 
Potential Biohazards of 
Recombinant DNA Molecules 
Recent advances in techniques for 
the isolation and rejoining of segments 
of DNA now permit construction of 
biologically active recombinant DNA 
molecules in vitro. For example. DNA 
restriction endonucleascs, which gen-
erate DNA fragments containing co-
hesive ends especially suitable for re-
joining. have been used to create new 
types of biologically functional bac-
terial plasmids carrying antibiotic re-
sistance markers (I) and to link 
Xenopus lael'is ribosomal DNA to 
DNA from a bacterial plasmid. This 
latter recombinant plasmid has been 
shown to replicate stably in Escherichia 
coli where it synthesizes RNA that is 
complementary to X. lat'l'is ribsomal 
DNA (2). Similarly. segments of 
Drosvphila chromosomal ON A have 
been incorporated into both plasmid 
and bacterillphagc ON A's to yield hy-
brid mokcules that can infect and 
replicate in C. coli Ln. 
Sevcr~tl groups of scientists arc now 
planning to usc this technology to 
create recombinant DNA's from a 
variety of other viral, animal, and 
hach:rial ~lllirccs. Althnugh such experi-
ments arc likely to facilitutc the solu-
tion of important theoretical and prac-
tical biologica I problems, they would 
also result in the creation of novel 
types of infectious ON A clements 
whose biological properties cannot be 
completely predicted in advance. 
There is scriO!JS concern that some of 
these artificial recombinant DNA mole-
cules could prove biologically hazard-
ous. One potential hazard in current 
experiments derives from the need to 
usc a hacteriun) like t:. coli to clone 
the recombinant ON A molecules and 
10 amplify their numb~.:r. Strains of 
£. coli commonly reside in the human 
intestinal tract, and they arc capable 
of exchanging genetic information with 
,,ther types l'f bacteria. some of which 
are pathl'gcnic to man. Thus, new 
DNA ekmcnts introduced into £. coli 
might possibly become widely dis-
.,eminatcd among human, bacterial, 
plant, or animal populations with un-
predictable elf ccts. 
Concern for these emerging capabili-
ties was raised hy scientists attending 
the 197 3 Gordon Research Confer-
ence on Nucleic Acids (4), who re-
quested that the National Academy of 
Sciences give consideration to these 
mattl·rs. Thl· undersigned member~ of 
a committee. acting on behalf of ami 
with the endorsement of the Assembly 
of Life Sciences of the National Re-
search Council on this matter. propose 
the following recommendations. 
First. and most important, that until 
the potential hazards of such recom-
binant ON A molecules have been better 
evaluated or until adequate methods 
arc developed for preventing their 
spread, scientists throughout the world 
join with the members of this com-
mittee in voluntarily deferring the fol-
lowing types of experiments. 
.,.. Type I: Construction of new, 
autonomously replicating bacterial plas-
mids that might result in the introduc-
tion of genetic determinants for anti-
biotic resistance or bacterial toxin 
formation into bacterial strains that dn 
not at present carry such determinants; 
or construction of new bacterial plas-
mids containing combinations of re-
sistance In clinically useful antibiotics 
unless plasmids containing such com-
binatillllS of antibiotic resistance de-
terminants alrc<tdy exist in nature. 
...,. Type 2; Linkage llf all or seg-
ments of the ON A's from oncogenic or 
other animal viruses to autonomously 
replicating DNA clements such as ba~­
tcrial plasm ids or other viral DNA's. 
Such recombinant DNA molecules 
might be more easily disscminatcJ to 
bacterial populations in humans and 
other species, nnd thus possibly in-
crease the incidence of cancer or other 
diseases. 
Second, ph111s to link fragments of 
animal DNA's to bacterial plasmid 
DNA or bacteriophage DNA should he 
carefully weighed in light of the fact 
that many types of animal cell DNA's 
cnntain SCI.JUCnccs common to RNA 
tumor viruses. Since jllining of any 
foreign DNA to a DNA replication 
system creates new recombinant ON A 
molecules whose biological prope rtics 
cannot be predicted with ccrt~Iinly, 
such experiments should not be under-
taken lightly. 
Third, the director of the National 
Institutes of Health is requested to give 
immediate consideration to establishing 
an advisory commiltce charged with 
( i) overseeing an experimental pro-
gram to evaluate the potential biologi-
cal and ecological hazards of the above 
types of recombinant ON A molecules; 
( ii) developing procedures which will 
minimize the spread of such molecules 
within human and other populations; 
an•l (iii) devising guidelines to be 
followed by investigators working with 
potentially hazardous recombinant 
ON A molecules. 
Fourth, an international meeting of 
involved scientists from all over the 
world should he convened early in the 
coming year to review scientific prog-
ress in this area and to furl her discuss 
appropriate ways to deal with the 
potential biohazards of recombinant 
DNA molecules. 
The above· recommendations are 
made with the realization (i) that 
our concern is based on judgments of 
potential rather than demonstrated risk 
since there arc few available experi-
mental data on the hazards of such 
DNA molecules and (ii) that adherence 
to our major recommendations will 
entail postponement or possibly aban-
donment of certain types of scientifical-
ly worthwhile experiments. Moreover, 
we arc aware of many theoretical and 
practical difficulties involved in evaluat-
ing the human hazards ofi such re-
combinant DNA molecules. Nonethe-
less. our concern for the possible un-
fortunate consequences of indiscrimi-
nate application of these techniques 
motivates us to urge all scientists work-
ing in this area to join us in agreeing 
not to initiate experiments of types 
I and 2 above until attempts have been 
made to evaluate the hazards and some 
resolution of the outstanding questions 
has been achieved. 
PAUL BERG, Chairman 
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STANLEY N. COHEN 
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